Ishita Drugs & Industries Share Price

BSE
ISHITADR •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Ishita Drugs & Industries Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
53.57% Gain from 52W Low
9.7
TTM PE Ratio
Below industry Median
34.6
Price to Book Ratio
Below industry Median
2.6
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
2.2

Ishita Drugs & Industries Ltd shareholding Pattern

Promoter
49.8%
Public
50.2%
Promoter
49.8%
Public
50.2%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%

Ishita Drugs & Industries Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
10
Bearish Moving Averages
6
5Day EMA
85.90
10Day EMA
86.70
12Day EMA
86.70
20Day EMA
86.20
26Day EMA
85.50
50Day EMA
83.40
100Day EMA
80.60
200Day EMA
77.00
5Day SMA
86.30
10Day SMA
87.30
20Day SMA
88.40
30Day SMA
84.30
50Day SMA
82.10
100Day SMA
81.30
150Day SMA
76.60
200Day SMA
74.60
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
2376 Rs
2397 Rs
Week Rs
1273 Rs
2010 Rs
Month Rs
5721 Rs
9613 Rs
Resistance & Support
85.03
Pivot
Resistance
First Resistance
86.07
Second Resistance
88.01
Third Resistance
89.05
Support
First Support
83.09
Second support
82.05
Third Support
80.11
Relative Strength Index
47.13
Money Flow Index
54.13
MACD
1.23
MACD Signal
2.04
Average True Range
4.20
Average Directional Index
13.84
Rate of Change (21)
17.06
Rate of Change (125)
28.31

Ishita Drugs & Industries Ltd Company background

Founded in: 1992
Managing director: Jagdish Agrawal
Ishita Drugs Industries Limited was incorporated in Feb.92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a stateofart manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms.The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana).Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.95. It established an inhouse RD laboratory which has developed a highly improved process technology for norfloxacin, which was implemented in the plant during Oct.95.The Company in 2009 undertook a small expansion cumdebottlenecking project it upgraded many existing equipments.
Read More

Ishita Drugs & Industries Ltd FAQs

You can easily buy Ishita Drugs & Industries Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -